In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
出版年份 2021 全文链接
标题
In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2
作者
关键词
SARS CoV 2, Point mutation, Ebola virus, Microbial mutation, Substitution mutation, Coronaviruses, Deletion mutation, Genomics
出版物
PLoS Pathogens
Volume 17, Issue 9, Pages e1009929
出版商
Public Library of Science (PLoS)
发表日期
2021-09-18
DOI
10.1371/journal.ppat.1009929
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes
- (2021) Kevin Chiem et al. JOURNAL OF VIROLOGY
- Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
- (2021) Goran Kokic et al. Nature Communications
- Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
- (2021) Zhuoming Liu et al. Cell Host & Microbe
- Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
- (2021) Allison J. Greaney et al. Cell Host & Microbe
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research
- (2021) Suzannah J. Rihn et al. PLOS BIOLOGY
- Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck
- (2021) Katarina M. Braun et al. PLoS Pathogens
- Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template
- (2021) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
- (2021) Thomas P. Peacock et al. Nature Microbiology
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
- (2020) Emmie de Wit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for RNA replication by the SARS-CoV-2 polymerase
- (2020) Quan Wang et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Structure of replicating SARS-CoV-2 polymerase
- (2020) Hauke S. Hillen et al. NATURE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
- (2020) Tyler N. Starr et al. CELL
- A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition
- (2020) M. Eugenia Dieterle et al. Cell Host & Microbe
- Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy
- (2020) Marie Helleberg et al. JOURNAL OF INFECTIOUS DISEASES
- Mutations Strengthened SARS-CoV-2 Infectivity
- (2020) Jiahui Chen et al. JOURNAL OF MOLECULAR BIOLOGY
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- Broad neutralization of SARS-related viruses by human monoclonal antibodies
- (2020) Anna Z. Wec et al. SCIENCE
- Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
- (2020) Andrea J. Pruijssers et al. Cell Reports
- Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
- (2020) Andrew D. Davidson et al. Genome Medicine
- Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets
- (2020) Chantal B. F. Vogels et al. Nature Microbiology
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
- (2020) Dorothea Bestle et al. Life Science Alliance
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action
- (2020) Egor P Tchesnokov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients
- (2020) William B. Klimstra et al. JOURNAL OF GENERAL VIROLOGY
- Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases
- (2020) Michael K. Lo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Growth, detection, quantification, and inactivation of SARS-CoV-2
- (2020) James Brett Case et al. VIROLOGY
- Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
- (2020) Matthew S. Buckland et al. Nature Communications
- Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
- (2020) Michael A Matthay et al. Lancet Respiratory Medicine
- Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland
- (2020) Ana da Silva Filipe et al. Nature Microbiology
- Minimap2: pairwise alignment for nucleotide sequences
- (2018) Heng Li BIOINFORMATICS
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Life cycle synchronization is a viral drug resistance mechanism
- (2018) Iulia A. Neagu et al. PLoS Computational Biology
- Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses
- (2017) Andrew E. Shaw et al. PLOS BIOLOGY
- Coronavirus NSP6 restricts autophagosome expansion
- (2014) Eleanor M Cottam et al. Autophagy
- Protter: interactive protein feature visualization and integration with experimental proteomic data
- (2013) Ulrich Omasits et al. BIOINFORMATICS
- Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
- (2013) Everett Clinton Smith et al. PLoS Pathogens
- Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus
- (2012) Kailang Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
- (2011) F. Sievers et al. Molecular Systems Biology
- Antiviral resistance and hepatitis B therapy
- (2010) Marc G. Ghany et al. HEPATOLOGY
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- Protease-Mediated Entry via the Endosome of Human Coronavirus 229E
- (2008) M. Kawase et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now